Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. Keeping that in mind, here are three profitable companies to avoid and some better opportunities instead.
onsemi (ON)
Trailing 12-month GAAP operating margin: 12.3%
Spun out of Motorola in 1999 and built through a series of acquisitions, onsemi (NASDAQ:ON) is a global provider of analog chips specializing in autos, industrial applications, and power management in cloud data centers.
Why Is ON Risky?
- Sales tumbled by 7.1% annually over the last two years, showing market trends are working against it during this cycle
- Competitive supply chain dynamics and steep production costs are reflected in its low gross margin of 37.6%
- Expenses have increased as a percentage of revenue over the last five years as its operating margin fell by 14.2 percentage points
At $70.83 per share, onsemi trades at 16.5x forward P/E. If you’re considering ON for your portfolio, see our FREE research report to learn more.
Brown-Forman (BF.B)
Trailing 12-month GAAP operating margin: 25.5%
Best known for its Jack Daniel’s whiskey, Brown-Forman (NYSE:BF.B) is an alcoholic beverage company with a broad portfolio of brands in wines and spirits.
Why Are We Cautious About BF.B?
- Sales tumbled by 2.4% annually over the last three years, showing consumer trends are working against it
- Demand will likely be weak over the next 12 months as Wall Street expects flat revenue
- Earnings per share have contracted by 2.1% annually over the last three years, a headwind for returns as stock prices often echo long-term EPS performance
Brown-Forman’s stock price of $30.81 implies a valuation ratio of 17.1x forward P/E. Check out our free in-depth research report to learn more about why BF.B doesn’t pass our bar.
Integer Holdings (ITGR)
Trailing 12-month GAAP operating margin: 8.2%
With its name reflecting the mathematical term for "whole" or "complete," Integer Holdings (NYSE:ITGR) is a medical device outsource manufacturer that produces components and systems for cardiac, vascular, neurological, and other medical applications.
Why Does ITGR Give Us Pause?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Modest revenue base of $1.83 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
Integer Holdings is trading at $126.65 per share, or 19.7x forward P/E. Read our free research report to see why you should think twice about including ITGR in your portfolio.
High-quality stocks for all market conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.